Abstract:Polymer drug conjugates have demonstrated application potentials in optimizing chemotherapeutics. In this study a new bioconjugate, HA-ss-PTX, was designed and synthesized with cooperative dual characteristics of active tumor targeting and selective intracellular drug release. Paclitaxel (PTX) was covalently attached to hyaluronic acid (HA) with various sizes (MW 9.5, 35, 770 kDa); a cross-linker containing disulfide bond was also used to shield drug leakage in blood circulation and to achieve rapid drug release in tumor cells in response to glutathione. Incorporation of HA to the conjugate enhanced the capabilities of drug loading, intracellular endocytosis and tumor targeting of micelles in comparison to mPEG. HA molecular weight showed significant effect on properties and antitumor efficacy of the synthesized conjugates. Intracellular uptake of HA-ss-PTX toward MCF-7 cells was mediated by CD44-caveolae-mediated endocytosis. Compared to Taxol and mPEG-ss-PTX, HA9.5-ss-PTX demonstrated improved tumor growth inhibition in vivo with a TIR of 83.27 +/- 5.20%. It was concluded that HA9.5-ss-PTX achieved rapid intracellular release of PTX and enhanced its therapeutic efficacy, thus providing a platform for specific drug targeting and controlled intracellular release in chemotherapeutics.Statement of SignificancePolymer drug conjugates, promising nanomedicines, still face some technical challenges including a lack of specific targeting and rapid intracellular drug release at the target site. In this manuscript we designed and constructed a novel bioconjugate HA-ss-PTX, which possessed coordinated dual characteristics of active tumor targeting and selective intracellular drug release. Redox-responsive disulfide bond was introduced to the conjugate to shield drug leakage in blood circulation and to achieve rapid drug release at tumor site in response to reductant like glutathione. Paclitaxel was selected as a model drug to be covalently attached to hyaluronic acid (HA) with various sizes to elucidate the structure activity relationship and to address whether HA could substitute PEG as a carrier for polymeric conjugates. Based on a series of in vitro and in vivo experiments, HA-ss-PTX performed well in drug loading, cellular internalization, tumor targeting by entering tumor cells via CD44-caveolae-mediated endocytosis and rapidly release drug at target in the presence of GSH. One of the key issues in clinical oncology is to enhance drug delivery efficacy while minimizing side effects. The study indicated that this new polymeric conjugate system would be useful in delivering anticancer agents to improve therapeutic efficacy and to minimize adverse effects, thus providing a platform for specific drug targeting and controlled intracellular release in chemotherapeutics. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Construction of polymer-paclitaxel conjugate linked via a disulfide bond.

Well-defined Polymer-Drug Conjugate Engineered with Redox and Ph-Sensitive Release Mechanism for Efficient Delivery of Paclitaxel.

Polymer–paclitaxel Conjugates Based on Disulfide Linkers for Controlled Drug Release

Preparation of Copolymer Paclitaxel Covalently Linked Via a Disulfide Bond and Its Application on Controlled Drug Delivery.

Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy

Preparation of Amphiphilic Copolymers for Covalent Loading of Paclitaxel for Drug Delivery System

Polymerizable Disulfide Paclitaxel Prodrug for Controlled Drug Delivery.

Amphiphilic conjugates for solubilization of paclitaxel as efficient drug carriers based on hyaluronic acid and cyclodextrins

Intracellular Delivery and Antitumor Effects of a Redox-Responsive Polymeric Paclitaxel Conjugate Based on Hyaluronic Acid.

Fabrication and reduction-sensitive behavior of polyion complex nano-micelles based on PEG-conjugated polymer containing disulfide bonds as a potential carrier of anti-tumor paclitaxel

Disulfide-Linked Amphiphilic Polymer-Docetaxel Conjugates Assembled Redox-Sensitive Micelles for Efficient Antitumor Drug Delivery

Mechanistic Study of the Covalent Loading of Paclitaxel Via Disulfide Linkers for Controlled Drug Release

Paclitaxel Solubilized Nanoparticles Based on Binding Affinity for Efficient Drug Delivery

Tunable paclitaxel release carrier using diselenide-disulfide balance as regulator

Self-assembly of Glutamic Acid Linked Paclitaxel Dimers into Nanoparticles for Chemotherapy

A Ph-Sensitive Polymeric Micellar System Based on Chitosan Derivative for Efficient Delivery of Paclitaxel

Polymers prepared through an "ATRP polymerization-esterification" strategy for dual temperature- and reduction-induced paclitaxel delivery

Synthesis and characterization of a novel polydepsipeptide contained tri-block copolymer (mPEG-PLLA-PMMD) as self-assembly micelle delivery system for paclitaxel.

Synthesis and Properties of the Poly(ε-caprolactone)-paclitaxel Prodrug

Tuning Paclitaxel Release Behavior Using Dually-Responsive Nanomicellar Assemblies with Multiple Diselenide/Disulfide Linkages

A Sulfobetaine Zwitterionic Polymer-Drug Conjugate For Multivalent Paclitaxel And Gemcitabine Co-Delivery